Year |
Citation |
Score |
2019 |
Underwood JJ, Quadri RS, Kalva SP, Shah H, Sanjeeviah AR, Beg MS, Sutphin PD. Liquid Biopsy for Cancer: Review and Implications for the Radiologist. Radiology. 182584. PMID 31746691 DOI: 10.1148/Radiol.2019182584 |
0.357 |
|
2019 |
Rodriguez S, Andring B, Nguyen T, Tellapuri S, Sutphin P, Kalva S. 03:09 PM Abstract No. 336 Renal angiomyolipoma: 3D volumetric assessment of tumor components to evaluate tumor reduction following embolization Journal of Vascular and Interventional Radiology. 30. DOI: 10.1016/J.Jvir.2018.12.406 |
0.35 |
|
2011 |
Chan DA, Sutphin PD, Nguyen P, Turcotte S, Lai EW, Banh A, Reynolds GE, Chi JT, Wu J, Solow-Cordero DE, Bonnet M, Flanagan JU, Bouley DM, Graves EE, Denny WA, et al. Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality. Science Translational Medicine. 3: 94ra70. PMID 21813754 DOI: 10.1126/Scitranslmed.3002394 |
0.719 |
|
2010 |
Hay MP, Turcotte S, Flanagan JU, Bonnet M, Chan DA, Sutphin PD, Nguyen P, Giaccia AJ, Denny WA. 4-Pyridylanilinothiazoles that selectively target von Hippel-Lindau deficient renal cell carcinoma cells by inducing autophagic cell death. Journal of Medicinal Chemistry. 53: 787-97. PMID 19994864 DOI: 10.1021/Jm901457W |
0.699 |
|
2009 |
Chan DA, Kawahara TL, Sutphin PD, Chang HY, Chi JT, Giaccia AJ. Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment. Cancer Cell. 15: 527-38. PMID 19477431 DOI: 10.1016/J.Ccr.2009.04.010 |
0.722 |
|
2008 |
Choi CY, Chan DA, Paulmurugan R, Sutphin PD, Le QT, Koong AC, Zundel W, Gambhir SS, Giaccia AJ. Molecular imaging of hypoxia-inducible factor 1 alpha and von Hippel-Lindau interaction in mice. Molecular Imaging. 7: 139-46. PMID 19123984 |
0.757 |
|
2008 |
Turcotte S, Sutphin PD, Giaccia AJ. Targeted therapy for the loss of von Hippel-Lindau in renal cell carcinoma: a novel molecule that induces autophagic cell death. Autophagy. 4: 944-6. PMID 18769110 DOI: 10.4161/Auto.6785 |
0.544 |
|
2008 |
Turcotte S, Chan DA, Sutphin PD, Hay MP, Denny WA, Giaccia AJ. A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell. 14: 90-102. PMID 18598947 DOI: 10.1016/J.Ccr.2008.06.004 |
0.713 |
|
2008 |
Giaccia AJ, Choi CYH, Chan DA, Paulmurugan R, Sutphin PD, Le QT, Koong AC, Zundel W, Gambhir SS. Molecular imaging of hypoxia-inducible factor 1α and von Hippel-Lindau interaction in mice Molecular Imaging. 7: 139-146. DOI: 10.2310/7290.2008.00017 |
0.738 |
|
2007 |
Cecic I, Chan DA, Sutphin PD, Ray P, Gambhir SS, Giaccia AJ, Graves EE. Oxygen sensitivity of reporter genes: implications for preclinical imaging of tumor hypoxia. Molecular Imaging. 6: 219-28. PMID 17711777 DOI: 10.2310/7290.2007.00017 |
0.711 |
|
2007 |
Sutphin PD, Chan DA, Li JM, Turcotte S, Krieg AJ, Giaccia AJ. Targeting the loss of the von Hippel-Lindau tumor suppressor gene in renal cell carcinoma cells. Cancer Research. 67: 5896-905. PMID 17575159 DOI: 10.1158/0008-5472.Can-07-0604 |
0.711 |
|
2007 |
Sutphin PD, Giaccia AJ, Chan DA. Energy regulation: HIF MXIes it up with the C-MYC powerhouse. Developmental Cell. 12: 845-6. PMID 17543856 DOI: 10.1016/J.Devcel.2007.05.006 |
0.688 |
|
2007 |
Cairns RA, Papandreou I, Sutphin PD, Denko NC. Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy. Proceedings of the National Academy of Sciences of the United States of America. 104: 9445-50. PMID 17517659 DOI: 10.1073/Pnas.0611662104 |
0.433 |
|
2007 |
Cecic I, Chan DA, Sutphin PD, Ray P, Gambhir SS, Giaccia AJ, Graves EE. Oxygen Sensitivity of Reporter Genes: Implications for Preclinical Imaging of Tumor Hypoxia Molecular Imaging. 6: 7290.2007.00017. DOI: 10.2310/7290.2007.00017 |
0.692 |
|
2006 |
Petrik D, Lavori PW, Cao H, Zhu Y, Wong P, Christofferson E, Kaplan MJ, Pinto HA, Sutphin P, Koong AC, Giaccia AJ, Le QT. Plasma osteopontin is an independent prognostic marker for head and neck cancers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 5291-7. PMID 17114663 DOI: 10.1200/Jco.2006.06.8627 |
0.567 |
|
2006 |
Dornhöfer N, Spong S, Bennewith K, Salim A, Klaus S, Kambham N, Wong C, Kaper F, Sutphin P, Nacamuli R, Nacalumi R, Höckel M, Le Q, Longaker M, Yang G, et al. Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis. Cancer Research. 66: 5816-27. PMID 16740721 DOI: 10.1158/0008-5472.Can-06-0081 |
0.771 |
|
2006 |
Dornhöfer N, Spong S, Bennewith K, Salim A, Klaus S, Kambham N, Wong C, Kaper F, Sutphin P, Nacamuli R, Höckel M, Le Q, Longaker M, Yang G, Koong A, et al. Erratum: Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis (Cancer Research (June 1, 2006) 66 (5816-5827)) Cancer Research. 66. DOI: 10.1158/0008-5472.Can-66-15-Cor |
0.756 |
|
2006 |
Choi C, Paulmurugan R, Chan D, Sutphin P, Le Q, Koong A, Gambhir S, Giaccia A. 83 International Journal of Radiation Oncology*Biology*Physics. 66: S48-S49. DOI: 10.1016/J.Ijrobp.2006.07.113 |
0.704 |
|
2005 |
Petrik DW, Cao H, Zhu Y, Wong P, Sutphin P, Giaccia AJ, Koong AA, Le QT. An expanded study of the relationship between osteopontin, tumor pO2 and prognosis in head and neck squamous cell carcinomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5521. PMID 27945243 DOI: 10.1200/Jco.2005.23.16_Suppl.5521 |
0.535 |
|
2005 |
Chan DA, Sutphin PD, Yen SE, Giaccia AJ. Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha. Molecular and Cellular Biology. 25: 6415-26. PMID 16024780 DOI: 10.1128/Mcb.25.15.6415-6426.2005 |
0.711 |
|
2005 |
Zhu Y, Denhardt DT, Cao H, Sutphin PD, Koong AC, Giaccia AJ, Le QT. Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer. Oncogene. 24: 6555-63. PMID 16007184 DOI: 10.1038/Sj.Onc.1208800 |
0.649 |
|
2004 |
Bemis L, Chan DA, Finkielstein CV, Qi L, Sutphin PD, Chen X, Stenmark K, Giaccia AJ, Zundel W. Distinct aerobic and hypoxic mechanisms of HIF-alpha regulation by CSN5. Genes & Development. 18: 739-44. PMID 15082527 DOI: 10.1101/Gad.1180104 |
0.752 |
|
2004 |
Sutphin PD, Chan DA, Giaccia AJ. Dead cells don't form tumors: HIF-dependent cytotoxins. Cell Cycle (Georgetown, Tex.). 3: 160-3. PMID 14712081 |
0.727 |
|
2004 |
Sutphin PD, Chan DA, Giaccia AJ. Dead Cells Don’t Form Tumors: HIF-Dependent Cytotoxins Cell Cycle. 3: 160-163. DOI: 10.4161/Cc.3.2.617 |
0.742 |
|
2003 |
Denko NC, Fontana LA, Hudson KM, Sutphin PD, Raychaudhuri S, Altman R, Giaccia AJ. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene. 22: 5907-14. PMID 12947397 DOI: 10.1038/Sj.Onc.1206703 |
0.555 |
|
2003 |
Le QT, Sutphin PD, Raychaudhuri S, Yu SC, Terris DJ, Lin HS, Lum B, Pinto HA, Koong AC, Giaccia AJ. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 59-67. PMID 12538452 |
0.599 |
|
2002 |
Chan DA, Sutphin PD, Denko NC, Giaccia AJ. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. The Journal of Biological Chemistry. 277: 40112-7. PMID 12186875 DOI: 10.1074/Jbc.M206922200 |
0.716 |
|
2002 |
Choi C, Fontana L, Sutphin P, Hammond E, Denko N, Giaccia A, Koong A, Le Q. Adipophilin: a novel hypoxia regulated gene International Journal of Radiation Oncology*Biology*Physics. 54: 121. DOI: 10.1016/S0360-3016(02)03265-0 |
0.591 |
|
2001 |
Koumenis C, Alarcon R, Hammond E, Sutphin P, Hoffman W, Murphy M, Derr J, Taya Y, Lowe SW, Kastan M, Giaccia A. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Molecular and Cellular Biology. 21: 1297-310. PMID 11158315 DOI: 10.1128/Mcb.21.4.1297-1310.2001 |
0.486 |
|
2001 |
Sutphin PD, Raychaudhuri S, Denko NC, Altman RB, Giaccia AJ. Application of supervised machine learning to identify genes associated with the hypoxia response Nature Genetics. 27: 90-90. DOI: 10.1038/87320 |
0.447 |
|
2001 |
Le Q, Sutphin P, Raychaudhuri S, Terris D, Lin H, Koong A, Chen U, Tibshirani R, Denko N, Giaccia A. Osteopontin - a new serum marker for tumor hypoxia International Journal of Radiation Oncology*Biology*Physics. 51: 80. DOI: 10.1016/S0360-3016(01)01971-X |
0.623 |
|
1998 |
Whitesell L, Sutphin PD, Pulcini EJ, Martinez JD, Cook PH. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent. Molecular and Cellular Biology. 18: 1517-24. PMID 9488468 DOI: 10.1128/Mcb.18.3.1517 |
0.323 |
|
1997 |
Whitesell L, Sutphin P, An WG, Schulte T, Blagosklonny MV, Neckers L. Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo. Oncogene. 14: 2809-2816. PMID 9190897 DOI: 10.1038/Sj.Onc.1201120 |
0.319 |
|
Show low-probability matches. |